Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

LENZ Therapeutics, Inc.

Close the merger with Graphite Bio

Delivered by the deadline

AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.

Announced
15 Nov 2023
Due
31 Mar 2024
Delivered
21 Mar 2024
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“The transaction has been unanimously approved by the Board of Directors of both companies and is expected to close in the first quarter of 2024”

What we found

Evidence strength A What the grades mean

The merger between LENZ Therapeutics and Graphite Bio was completed in March 2024, which falls within the first quarter of 2024.

  • A
    LENZ Therapeutics, Inc. 10-K filed 2025-03-19 Regulatory filing · published 19 Mar 2025 · retrieved 2 Oct 2026 · kept permanently by the SEC · fingerprint ca06f8f12bc2
    “Resigned from the board of directors on March 21, 2024, effective as of the effective time of the Merger.” ✓ confirmed on the page

Market reaction: the shares moved +7.7% against the S&P 500 over the three sessions around the disclosure (18 Mar 2025 to 21 Mar 2025). What this measures

Checked 2 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Merger
Indicative materiality
Transformational rules
Action
Close
Deliverable
Merger with Graphite Bio
Language
Expected (“expects”, “plans”)
In the company’s control
Medium
Specificity
High
Conditional
Yes: stockholder approval; customary closing conditions
Depends on
Shareholder

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.

Confirmed. This outcome counts towards the company's Kept Score. How verification works

Are you LENZ Therapeutics, Inc.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2023-LENZ-003354 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.